Connection

Michel Nussenzweig to Viremia

Back to Details
This is a "connection" page, showing publications Michel Nussenzweig has written about Viremia.
Michel Nussenzweig
Connection Strength
0.761
Viremia
  1. Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals. Nat Med. 2018 11; 24(11):1701-1707.
    View in: PubMed
    Score: 0.435
  2. Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature. 2018 09; 561(7724):479-484.
    View in: PubMed
    Score: 0.109
  3. Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller. Sci Transl Med. 2017 01 18; 9(373).
    View in: PubMed
    Score: 0.097
  4. Antibody 10-1074 suppresses viremia in HIV-1-infected individuals. Nat Med. 2017 Feb; 23(2):185-191.
    View in: PubMed
    Score: 0.097
  5. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017 03 23; 543(7646):559-563.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.